PO-629-02 NEW EVIDENCE TO CHALLENGE CLINGEN'S “DISPUTED EVIDENCE” DESIGNATION FOR AKAP9 AS A BONA FIDE SUSCEPTIBILITY GENE FOR CONGENITAL LONG QT SYNDROME von Huffman, Elliana, Ye, Dan, Zhou, Wei, Tester, David J., Giudicessi, John R., Ackerman, Michael John

Volltext

PO-04-105 ELUCIDATION OF THE PREVALENCE, SPECTRUM, AND OUTCOMES IN PATIENTS WITH NON-PENETRANT LONG QT SYNDROME von Huffman, Elliana, Neves, Raquel A., Bos, Johan M., Bains, Sahej, MacIntyre, Ciorsti J., Giudicessi, John R., Ackerman, Michael J.

Volltext

PO-03-231 BREAKTHROUGH CARDIAC EVENT RATE OF INITIALLY ASYMPTOMATIC LQTS PATIENTS von Huffman, Elliana, Neves, Raquel A., Bos, Johan M., Bains, Sahej, MacIntyre, Ciorsti J., Giudicessi, John R., Ackerman, Michael J.

Volltext

Phosphatidylserine orchestrates Myomerger membrane insertions to drive myoblast fusion von Gamage, Dilani G., Melikov, Kamran, Munoz-Tello, Paola, Wherley, Tanner J., Focke, Leah C., Leikina, Evgenia, Huffman, Elliana, Diao, Jiajie, Kojetin, Douglas J., Prasad, Vikram, Chernomordik, Leonid V., Millay, Douglas P.

Volltext